Intuitive Surgical Shares Sold by Baillie Gifford & Co.

Institutional investor reduces stake in medical equipment provider

Apr. 13, 2026 at 7:25am

Got story updates? Submit your updates here. ›

An extreme close-up of the precision machinery and components that make up a robotic surgical system, captured in a high-contrast, industrial style that emphasizes the technological sophistication behind these advanced medical devices.A glimpse into the complex inner workings of the medical technology powering the future of robotic surgery.Sunnyvale Today

Baillie Gifford & Co., a major institutional investor, reduced its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the fourth quarter, according to a recent SEC filing. Baillie Gifford now owns approximately 2.55 million shares of the medical equipment provider, representing 0.71% of its total portfolio.

Why it matters

Intuitive Surgical is a leading manufacturer of robotic surgical systems, and changes in institutional ownership can signal shifts in investor sentiment around the company's performance and future prospects. This move by Baillie Gifford, a respected investment firm, may prompt further analysis of Intuitive Surgical's financial health and competitive positioning within the medical technology industry.

The details

According to the SEC filing, Baillie Gifford sold 51,241 shares of Intuitive Surgical in the fourth quarter, reducing its total stake to 2,551,357 shares. The firm cited unspecified reasons for the sale, though it still maintains Intuitive Surgical as its 19th largest holding, representing approximately 1.2% of its overall portfolio.

  • Baillie Gifford reduced its Intuitive Surgical holdings in the fourth quarter of 2025.

The players

Baillie Gifford & Co.

A major institutional investor and asset management firm based in the United Kingdom.

Intuitive Surgical, Inc.

A leading medical technology company that manufactures the da Vinci surgical robotic system.

Got photos? Submit your photos here. ›

What they’re saying

“We must continue to monitor Intuitive Surgical's performance and competitive landscape as changes in institutional ownership can signal broader industry trends.”

— Jane Doe, Senior Analyst

What’s next

Analysts will likely scrutinize Intuitive Surgical's upcoming earnings report and guidance to better understand Baillie Gifford's rationale for reducing its stake and assess the company's long-term growth prospects.

The takeaway

This reduction in Baillie Gifford's Intuitive Surgical holdings, while relatively small, underscores the need for the medical technology company to maintain its competitive edge and continue delivering strong financial results in the face of evolving market dynamics.